K
v
ire
.com
←
Back
Night
Docs
Library
Critique
…
Author
Brigitte Dréno
also known as B DRENO, B Dreno, B Drèno
Centre National de la Recherche Scientifique · Inserm · Nantes Université · Université Claude Bernard Lyon 1
About this author
Works
1,453
Cited by
66,847
h-index
104
i10
560
ORCID ↗
Top papers
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González, et al.
·
2015
·
New England Journal of Medicine
↗ 8,093
OA
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert, et al.
·
2011
·
New England Journal of Medicine
↗ 7,670
OA
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty, Caroline Robert, Peter Hersey, et al.
·
2012
·
New England Journal of Medicine
↗ 2,136
OA
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
James Larkin, Paolo A. Ascierto, Brigitte Dréno, et al.
·
2014
·
New England Journal of Medicine
↗ 2,024
OA
Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group
Keith T. Flaherty, Caroline Robert, Peter Hersey, et al.
·
2012
·
Zurich Open Repository and Archive (University of Zurich)
↗ 1,342
OA
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson, et al.
·
2000
·
Journal of Clinical Oncology
↗ 1,265
Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Paolo A. Ascierto, Grant A. McArthur, Brigitte Dréno, et al.
·
2016
·
The Lancet Oncology
↗ 1,002
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
Grant A. McArthur, Paul B. Chapman, Caroline Robert, et al.
·
2014
·
The Lancet Oncology
↗ 976
New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group
Diane Thiboutot, Harald Gollnick, Vincenzo Bettoli, et al.
·
2009
·
Journal of the American Academy of Dermatology
↗ 830
Management of Acne
Harald Gollnick, W.J. Cunliffe, Diane Berson, et al.
·
2003
·
Journal of the American Academy of Dermatology
↗ 816
Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma
Antoni Ribas, Richard Kefford, Margaret Marshall, et al.
·
2013
·
Journal of Clinical Oncology
↗ 813
OA
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens
Jacques Dantal, Maryvonne Hourmant, Diego Cantarovich, et al.
·
1998
·
The Lancet
↗ 746